Lone Star Funds Affiliate to Acquire Lonza Capsules & Health Ingredients Division

Lone Star Funds Affiliate Acquires Hillenbrand in $3.8 Billion All-Cash Deal

February 10, 2026

Industrial Services

Lone Star Funds, through an affiliate, completed the previously announced all-cash acquisition of Hillenbrand, Inc. in a transaction valued at approximately $3.8 billion (about $32 per share). Following closing, Hillenbrand’s common stock ceased trading and the company will operate as a privately held business under the Hillenbrand name.

HCAP Partners Acquires Lone Star Analysis

October 7, 2021

Data & Analytics

HCAP Partners announced a follow-on equity investment in Dallas-area Lone Star Analysis and exercised its full purchase option to take control of the firm. The funding will support strategic growth initiatives and R&D to build out new enterprise analytics and AI software; terms were not disclosed.

Lonza Group AG Acquires Synaffix B.V.

June 1, 2023

Biotechnology

Lonza Group AG has acquired Synaffix B.V., a Netherlands-based biotech company that commercialises a clinical-stage antibody-drug conjugate (ADC) technology platform. The deal brings Synaffix's ADC bioconjugation technology into Lonza's integrated ADC development and manufacturing offering to accelerate discovery, development, scale-up and commercialization of ADCs.

Lone Star Affiliate Acquires Titan Acquisition Holdings from Carlyle and Stellex

June 29, 2023

Industrial Services

An affiliate of Lone Star Funds has completed the acquisition of Titan Acquisition Holdings — the parent of Vigor Industrial LLC, MHI Holdings LLC and Continental Maritime of San Diego — from funds managed by The Carlyle Group and Stellex Capital Management. The transaction, first announced in February 2023, closed in mid-June 2023; financial terms were not disclosed. Titan is a bi-coastal leader in ship repair, marine and heavy fabrication serving U.S. government and commercial maritime customers.

Linden Capital Partners Acquires LifeStyles Healthcare

December 1, 2022

Consumer Products

Linden Capital Partners has acquired LifeStyles Healthcare, a global sexual health and wellness platform, from a consortium of investors including Trustar Capital and Humanwell Healthcare. The deal excludes LifeStyles' Chinese operations (including the Jissbon brand), which will be retained by the selling shareholders; Linden has named Laurent Faracci as incoming CEO and Ron Fugate as Chairman to drive commercial, brand, and innovation-led growth.

Turnspire Capital Partners Completes Acquisition of Pharmachem Innovations from Ashland

September 3, 2024

Food & Beverage

Turnspire Capital Partners has acquired Pharmachem Innovations, the former nutraceuticals business of Ashland Inc., creating an independent nutraceuticals platform. Pharmachem — a provider of proprietary nutrition ingredients, custom formulation and contract manufacturing with ~500 employees across facilities in New Jersey, Utah and Tamaulipas, Mexico — will be led by Executive Chairman Maurice Murphy and Interim CEO Jeff Rogers as Turnspire pursues operational growth opportunities.